OTCQB:EMHTF - Post by User
Post by
toooldtosaveon Apr 29, 2020 1:15pm
150 Views
Post# 30967119
News
News
Emerald Health Therapeutics to Launch Rapid Onset Nanoemulsion Cannabinoid & Terpene Product Line, Providing Consumers with Enhanced Immediacy and Control
Unique product line uses advanced technology to improve cannabinoid absorption by roughly 65% to provide more predictable dosing, onset and effects, as well as discreetness and value, of THC and CBD products for medicinal and adult-use users
VANCOUVER, April 29, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) is announcing its new nanoemulsion-based Fast Action Spray product line, an important step in Emerald’s Cannabis 2.0 strategy and a unique offering in the Canadian cannabis marketplace. This unique formulation offers notable advantages over existing formats of cannabis consumption in terms of convenience and predictability of consumption. The product line will consist of CBD and THC cannabinoids mixed with specific terpenes and flavorings. The first product is planned for launch in June.
See the full article on Yahoo finance